Details

Autor(en) / Beteiligte

• Hu, Qiang
• Jiao, Xiong
• Wei, YanYan
• Tang, XiaoChen
• Xu, LiHua
• Cui, HuiRu
• Hu, YeGang
• Tang, YingYing
• Wang, ZiXuan
• Chen, Tao
• Liu, HaiChun
• Li, ChunBo
• An, CuiXia
• Wang, JiJun
• Zhang, TianHong

Titel

Repetitive transcranial magnetic stimulation can improve negative symptoms and/or neurocognitive impairments in the first psychosis episode: A randomized controlled trial

Ist Teil von

• Progress in neuro-psychopharmacology & biological psychiatry, 2024-07, Vol.133, p.111017, Article 111017

Ort / Verlag

England: Elsevier Inc

Erscheinungsjahr

2024

Quelle

Alma/SFX Local Collection

Beschreibungen/Notizen

• Negative symptoms and neurocognitive impairments in psychosis correlate with their severity. Currently, there is no satisfactory treatment. We aimed to evaluate and compare the effects of repetitive transcranial magnetic stimulation(rTMS) on negative symptoms and neurocognitive impairments in patients in first-episode of psychosis(FEP) in a randomized controlled trial(RCT). This is a single-site RCT of 85 patients with FEP. Patients were randomized to receive a 4-week course of active(n = 45) or sham rTMS(n = 40). Factor analysis was applied to a cross-sectional dataset of 744 FEP patients who completed negative symptom evaluation and neurocognitive battery tests. Two independent dimensions were generated and used for the K-means cluster analysis to produce sub-clusters. rTMS of 1-Hz was delivered to the right orbitofrontal(OFC) cortex. Two distinct dimensional factors of neurocognitive functions(factor-1) and negative symptoms(factor-2), and three clusters with distinctive features were generated. Significant improvements in factor-1 and factor-2 were observed after 4-weeks of rTMS treatment in both the active and sham rTMS groups. The repeated-measures analysis of variance revealed a significant effect of time×group(F = 5.594, p = 0.021, η2 = 0.073) on factor-2, but no effect of time×group on factor-1. Only improvements in negative symptoms were significantly different between the active and sham rTMS groups(p = 0.028). Patients in cluster-3 characterized by extensive negative symptoms, showed greater improvement in the active rTMS group than in the sham rTMS group. The 1-Hz right OFC cortex rTMS is more effective in reducing negative symptoms than neurocognitive impairments. It is especially effective in patients with dominantly negative symptoms in FEP. •Dimensional factors are identified in first-episode psychosis(FEP) patients - neurocognitive functions and negative symptoms.•The 1-Hz right right orbitofrontal(OFC) cortex rTMS is more effective in reducing negative symptoms than neurocognitive impairments.•Add-on rTMS is particularly beneficial for individuals with predominantly negative symptoms in FEP.